NCT00426205
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +7 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Refractory CML Myeloid Blast Crisis
Explore clinical trials studying Refractory CML Myeloid Blast Crisis. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies